Medications used to treat Parkinson’s disease and the risk of gambling
Identifieur interne : 000D53 ( Main/Exploration ); précédent : 000D52; suivant : 000D54Medications used to treat Parkinson’s disease and the risk of gambling
Auteurs : A. Imamura [États-Unis] ; Y. E. Geda [États-Unis] ; J. Slowinski [États-Unis] ; Z. K. Wszolek [États-Unis] ; L. A. Brown [États-Unis] ; R. J. Uitti [États-Unis]Source :
- European Journal of Neurology [ 1351-5101 ] ; 2008-04.
English descriptors
- KwdEn :
Abstract
Recent case–series studies indicated that a medication used to treat Parkinson’s disease (PD), in particular Pramipexole, is associated with gambling. A case–series study cannot test this hypothesis; therefore, we need to design a case–control or cohort study to test the aforementioned hypothesis. Typical of a case–control design, we sampled on the dependent variable, which we defined as incident gambling in PD. A research neurologist, who was kept uninformed of the case–control status, retrospectively measured the exposure of interest (i.e. medications used to treat PD) by using the medical database system of Mayo Clinic Jacksonville. Eleven patients with PD without history of gambling, but had newly developed gambling, were matched by age and sex to the control group of 37 PD patients without gambling at a ratio of one case to at least three controls. Disease duration, age, and sex did not differ between cases and controls. Combined therapy with Pramipexole and levodopa did not increase the risk of gambling as compared to monotherapy with Pramipexole (OR, 0.15; 95% CI, 0.01–1.26). Treatment with Pramipexole was associated with increased risk of gambling and this association approached significance (OR, 3.6; 95% CI, 0.9–14.9). Patients with PD who newly developed gambling behavior were more likely to have been taking Pramipexole than other anti‐PD medication. However, the association between Pramipexole and gambling behavior is not necessarily etiologic.
Url:
DOI: 10.1111/j.1468-1331.2008.02081.x
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Medications used to treat Parkinson’s disease and the risk of gambling</title><author><name sortKey="Imamura, A" sort="Imamura, A" uniqKey="Imamura A" first="A." last="Imamura">A. Imamura</name></author><author><name sortKey="Geda, Y E" sort="Geda, Y E" uniqKey="Geda Y" first="Y. E." last="Geda">Y. E. Geda</name></author><author><name sortKey="Slowinski, J" sort="Slowinski, J" uniqKey="Slowinski J" first="J." last="Slowinski">J. Slowinski</name></author><author><name sortKey="Wszolek, Z K" sort="Wszolek, Z K" uniqKey="Wszolek Z" first="Z. K." last="Wszolek">Z. K. Wszolek</name></author><author><name sortKey="Brown, L A" sort="Brown, L A" uniqKey="Brown L" first="L. A." last="Brown">L. A. Brown</name></author><author><name sortKey="Uitti, R J" sort="Uitti, R J" uniqKey="Uitti R" first="R. J." last="Uitti">R. J. Uitti</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:7C36C19E46B535CC72669075F907B3EC68B2AF2C</idno><date when="2008" year="2008">2008</date><idno type="doi">10.1111/j.1468-1331.2008.02081.x</idno><idno type="url">https://api.istex.fr/document/7C36C19E46B535CC72669075F907B3EC68B2AF2C/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">001021</idno><idno type="wicri:Area/Main/Curation">000E33</idno><idno type="wicri:Area/Main/Exploration">000D53</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Medications used to treat Parkinson’s disease and the risk of gambling</title><author><name sortKey="Imamura, A" sort="Imamura, A" uniqKey="Imamura A" first="A." last="Imamura">A. Imamura</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Mayo Clinic, Jacksonville, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author><author><name sortKey="Geda, Y E" sort="Geda, Y E" uniqKey="Geda Y" first="Y. E." last="Geda">Y. E. Geda</name><affiliation><wicri:noCountry code="no comma">Department of Psychiatry and Psychology</wicri:noCountry></affiliation><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation></author><author><name sortKey="Slowinski, J" sort="Slowinski, J" uniqKey="Slowinski J" first="J." last="Slowinski">J. Slowinski</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Mayo Clinic, Jacksonville, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author><author><name sortKey="Wszolek, Z K" sort="Wszolek, Z K" uniqKey="Wszolek Z" first="Z. K." last="Wszolek">Z. K. Wszolek</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Mayo Clinic, Jacksonville, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author><author><name sortKey="Brown, L A" sort="Brown, L A" uniqKey="Brown L" first="L. A." last="Brown">L. A. Brown</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Mayo Clinic, Jacksonville, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author><author><name sortKey="Uitti, R J" sort="Uitti, R J" uniqKey="Uitti R" first="R. J." last="Uitti">R. J. Uitti</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Mayo Clinic, Jacksonville, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">European Journal of Neurology</title><idno type="ISSN">1351-5101</idno><idno type="eISSN">1468-1331</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2008-04">2008-04</date><biblScope unit="volume">15</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="350">350</biblScope><biblScope unit="page" to="354">354</biblScope></imprint><idno type="ISSN">1351-5101</idno></series><idno type="istex">7C36C19E46B535CC72669075F907B3EC68B2AF2C</idno><idno type="DOI">10.1111/j.1468-1331.2008.02081.x</idno><idno type="ArticleID">ENE2081</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1351-5101</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson’s disease</term><term>Pramipexole</term><term>gambling</term><term>hypothesis testing</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Recent case–series studies indicated that a medication used to treat Parkinson’s disease (PD), in particular Pramipexole, is associated with gambling. A case–series study cannot test this hypothesis; therefore, we need to design a case–control or cohort study to test the aforementioned hypothesis. Typical of a case–control design, we sampled on the dependent variable, which we defined as incident gambling in PD. A research neurologist, who was kept uninformed of the case–control status, retrospectively measured the exposure of interest (i.e. medications used to treat PD) by using the medical database system of Mayo Clinic Jacksonville. Eleven patients with PD without history of gambling, but had newly developed gambling, were matched by age and sex to the control group of 37 PD patients without gambling at a ratio of one case to at least three controls. Disease duration, age, and sex did not differ between cases and controls. Combined therapy with Pramipexole and levodopa did not increase the risk of gambling as compared to monotherapy with Pramipexole (OR, 0.15; 95% CI, 0.01–1.26). Treatment with Pramipexole was associated with increased risk of gambling and this association approached significance (OR, 3.6; 95% CI, 0.9–14.9). Patients with PD who newly developed gambling behavior were more likely to have been taking Pramipexole than other anti‐PD medication. However, the association between Pramipexole and gambling behavior is not necessarily etiologic.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Floride</li><li>Minnesota</li></region></list><tree><country name="États-Unis"><region name="Floride"><name sortKey="Imamura, A" sort="Imamura, A" uniqKey="Imamura A" first="A." last="Imamura">A. Imamura</name></region><name sortKey="Brown, L A" sort="Brown, L A" uniqKey="Brown L" first="L. A." last="Brown">L. A. Brown</name><name sortKey="Geda, Y E" sort="Geda, Y E" uniqKey="Geda Y" first="Y. E." last="Geda">Y. E. Geda</name><name sortKey="Slowinski, J" sort="Slowinski, J" uniqKey="Slowinski J" first="J." last="Slowinski">J. Slowinski</name><name sortKey="Uitti, R J" sort="Uitti, R J" uniqKey="Uitti R" first="R. J." last="Uitti">R. J. Uitti</name><name sortKey="Wszolek, Z K" sort="Wszolek, Z K" uniqKey="Wszolek Z" first="Z. K." last="Wszolek">Z. K. Wszolek</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D53 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000D53 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:7C36C19E46B535CC72669075F907B3EC68B2AF2C
|texte= Medications used to treat Parkinson’s disease and the risk of gambling
}}
| This area was generated with Dilib version V0.6.23. |  |